Gautam Patel is Director of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 2.05 Million shares of AMRX, which is worth approximately $17.4 Million. The most recent transaction as insider was on May 10, 2024, when has been sold 76,453 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.05M
0% 3M change
447.37% 12M change
Total Value Held $17.4 Million

Gautam Patel Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2024
BUY
Exercise of conversion of derivative security
-
76,453 Added 3.6%
2,048,886 Class A Common Stock
Jan 01 2024
SELL
Other acquisition or disposition
-
33,458,067 Reduced 98.89%
374,318 Class A Common Stock
Jan 01 2024
BUY
Bona fide gift
-
1,598,115 Added 44.76%
1,972,433 Class A Common Stock
May 10 2023
BUY
Exercise of conversion of derivative security
-
80,128 Added 17.63%
374,318 Class A Common Stock
May 08 2022
BUY
Exercise of conversion of derivative security
-
35,406 Added 10.74%
294,190 Class A Common Stock
Dec 17 2021
BUY
Open market or private purchase
$210,500 $4.21 p/Share
50,000 Added 16.19%
258,784 Class A Common Stock
May 06 2021
BUY
Exercise of conversion of derivative security
-
46,218 Added 18.12%
208,784 Class A Common Stock

Also insider at

SPB
Spectrum Brands Holdings, Inc. Consumer Defensive
GP

Gautam Patel

Director
Middleton, WI

Track Institutional and Insider Activities on AMRX

Follow Amneal Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX